People in the News
Sirna Therapeutics said this week that it has named Gregory Weaver as CFO.
Weaver replaces Martin Schmieg, who resigned from the company last year.
According to Sirna, Weaver most recently served as CFO of Nastech Pharmaceutical. Before that, he was CFO of Ilex Oncology. He has a BS from Trinity University and an MBA from Boston College Graduate School of Management.